VC-backed Progyny debuts IPO
Progyny, a fertility benefits management company, has raised $130 million for its IPO after pricing its 10 million shares at $13 per share. The stock began trading October 25, 2019 on the NASDAQ under the ticker symbol "PGNY." JP Morgan, Goldman Sachs and BofA Securities are the lead underwriters. Progyny's pre-IPO backers include Kleiner Perkins, TPG Biotech and Union Grove Venture Partners.
25 October 2019•3 mins read
